Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2025 | 06-2025 | 06-2024 | 06-2023 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -3,584 | -4,363 | -6,062 | -7,595 |
| Depreciation Amortization | N/A | 78 | 306 | 293 | 150 |
| Other Working Capital | N/A | 19 | -585 | -509 | -1,024 |
| Other Operating Activity | -2,592 | 373 | 640 | 1,315 | 3,202 |
| Operating Cash Flow | $-2,592 | $-3,114 | $-4,002 | $-4,963 | $-5,267 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,504 | N/A | N/A | N/A | N/A |
| PPE Investments | N/A | -153 | -5 | -26 | -781 |
| Other Investing Activity | 0 | 2,839 | 5,248 | 85 | -10,000 |
| Investing Cash Flow | $2,504 | $2,686 | $5,243 | $59 | $-10,781 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 102 | 135 | 22,406 |
| Financing Cash Flow | $N/A | $0 | $102 | $135 | $22,406 |
| Exchange Rate Effect | 26 | -115 | 53 | -83 | 0 |
| Beginning Cash Position | 2,419 | 2,961 | 1,565 | 6,417 | 59 |
| End Cash Position | 2,357 | 2,419 | 2,961 | 1,565 | 6,417 |
| Net Cash Flow | $-62 | $-542 | $1,396 | $-4,852 | $6,358 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,592 | -3,114 | -4,002 | -4,963 | -5,267 |
| Free Cash Flow | -2,592 | -3,114 | -4,002 | -4,963 | -5,267 |